Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Other Non-Current Liabilities (2015 - 2024)

Palatin Technologies' (PTN) quarterly Other Non-Current Liabilities came in at $1.1 million in Q3 2024, down 45.41% YoY from $2.0 million in Q4 2023, and up 7.21% on a QoQ basis from $1.0 million in Q1 2024.

Palatin Technologies (PTN) Other Non-Current Liabilities (2015 - 2024) Analysis & Trends

Palatin Technologies (PTN) has 10 years of Other Non-Current Liabilities data on file, last reported at $1.1 million in Q3 2024.

  • Quarterly Other Non-Current Liabilities fell 45.41% year-over-year to $1.1 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $1.1 million (down 45.41% YoY) and the FY2023 annual result came in at $1.9 million, down 35.32% from the prior year.
  • Other Non-Current Liabilities grew to $1.1 million in Q3 2024, from $1.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $10.8 million in Q4 2020 to a low of $9062.0 in Q1 2020.
  • A 5-year average of $3.9 million and a median of $3.0 million in 2022 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2020 — Other Non-Current Liabilities soared 80247.72% — and 2024, when it slumped 72.63%.
  • Tracing PTN's Other Non-Current Liabilities over 5 years: stood at $10.8 million in 2020, then sank by 72.19% to $3.0 million in 2021, then advanced by 23.87% to $3.7 million in 2022, then plunged by 70.35% to $1.1 million in 2023, then changed by 0.0% to $1.1 million in 2024.
  • The last three Other Non-Current Liabilities figures came in at $1.1 million (Q3 2024), $1.0 million (Q1 2024), and $1.1 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Palatin Technologies 40.37 Mn 40.37 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 1.11 Mn
Mar 31, 2024 1.03 Mn
Dec 31, 2023 1.11 Mn
Sep 30, 2023 2.03 Mn
Jun 30, 2023 1.85 Mn
Mar 31, 2023 3.77 Mn
Dec 31, 2022 3.73 Mn
Sep 30, 2022 2.74 Mn
Jun 30, 2022 2.86 Mn
Mar 31, 2022 3.00 Mn
Dec 31, 2021 3.01 Mn
Sep 30, 2021 6.17 Mn
Jun 30, 2021 6.23 Mn
Mar 31, 2021 6.97 Mn
Dec 31, 2020 10.84 Mn
Sep 30, 2020 10.62 Mn
Mar 31, 2020 9,062.00
Dec 31, 2019 13,488.00
Jun 30, 2018 456,038.00
Mar 31, 2018 909,179.00